Registry to Evaluate Long-Term Outcomes in Patients Who Undergo 68-Ga-PSMA-11 PET/CT Imaging Evaluations

Clinical trial NCT06655064 · TERMINATED

Trial details

NCT number: NCT06655064
Sponsor: Telix Pharmaceuticals (Innovations) Pty Limited
Status: TERMINATED
Study type: OBSERVATIONAL

Prostate Cancer (Adenocarcinoma)

Start date: 2025-01-30
Primary completion: 2025-06-17
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.